[Paroxysmal atrial fibrillation].
Lewalter
T
T
Medizinische Klinik und Poliklinik II Rheinische Freidrich-Wilhelms-Universität, Bonn. Th.Lewalter@Uni-Bonn.de
Lüderitz
B
B
D000638:Amiodarone / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D017115:Catheter Ablation; D004554:Electric Countershock; D005260:Female; D006801:Humans; D008875:Middle Aged; D008991:Monitoring, Physiologic; D010138:Pacemaker, Artificial; D011379:Prognosis; D011802:Quinidine / Q000627:therapeutic use; D012008:Recurrence; D012307:Risk Factors; D013015:Sotalol / Q000627:therapeutic use; D013923:Thromboembolism / Q000517:prevention & control; D014665:Vasodilator Agents / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D014665:Vasodilator Agents; D013015:Sotalol; D011802:Quinidine; D000638:Amiodarone